MOA Study of Ze 339 in Seasonal Allergic Rhinitis

NCT00862225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Placebo
DRUG: Desloratadin
DRUG: IG-RD-001 / Ze 339

Sponsor

Max Zeller Soehne AG